Please check the individual session for location or broadcast availability.
Christopher Amos, PhD
Target Audience and Needs
Most medical professionals have insufficient knowledge about the role that precision medicine has in clinical practice. Genetic alterations affect all types of cancer and often affect cardiovascular, autoimmune, and neurological diseases as well. Laboratory tools used in precision medicine are highly sophisticated and include genomics, proteomics, and other high-dimensional assays. The series will provide regular updates on these tools, the ways the tools could improve patient care, and the ethical and legal issues surrounding genetic testing. The series will also examine how testing for genetically influenced diseases can affect personalized management of individuals and their families.
Educational methods will include lectures.
At the conclusion of the sessions, the participants should be able to:
- Discuss the challenges of implementing precision medicine in clinical practice for patients with cancer and those with cardiovascular, autoimmune, and neurological diseases.
- Support precision medicine practices through enhanced training in genomics, proteomics, and other high-dimensional assays.
- Explain the fundamentals of precision medicine, the assays used for measurement, and the ways in which results of those assays inform personalized therapy.
- Summarize the ethical and legal issues related to precision medicine and the ways in which those issues affect patients with disparate family genetic histories and socioeconomic backgrounds.
- Describe patient-centered care as it relates to oncology.
- Develop patient-centered outcomes measures, including quality of life and patient experience, to assess precision medical care.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.